Assessment of serum sodium to urinary sodium divided by (serum potassium)2 to urinary potassium as a screening tool for primary aldosteronism

European Journal of Clinical Investigation

Volumn 41, Issue 2, 2011, Pages 189-194

  Steichen, Olivier ^a,b   Blanchard, Anne ^a,b   Plouin, Pierre François ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Diagnosis; Hyperaldosteronism; Hypertension; Hypokalemia; Potassium; Sensitivity and specificity

Indexed keywords

ALDOSTERONE; POTASSIUM; RENIN; SODIUM;

ADULT; ALDOSTERONE BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POTASSIUM URINE LEVEL; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCREENING; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE;

ADULT; FEMALE; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; POTASSIUM; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SODIUM;

EID: 78651320470     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02401.x     Document Type: Article

References (19)

1. Jansen PM, Boomsma F, van den Meiracker AH. Aldosterone-to-renin ratio as a screening test for primary aldosteronism - the Dutch ARRAT Study. Neth J Med 2008;66:220-8.
2. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008;93:3266-81.
3. Kaplan NM. The current epidemic of primary aldosteronism: causes and consequences. J Hypertens 2004;22:863-9.
4. Arlt W. A detour guide to the Endocrine Society Clinical Practice Guideline on case detection, diagnosis and treatment of patients with primary aldosteronism. Eur J Endocrinol 2010;162:435-8.
5. Haute Autorité de Santé. Prise en charge des patients adultes atteints d'hypertension artérielle essentielle - Actualisation 2005. J Mal Vasc 2006;31:16-33.
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72.
7. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press 2007;16:135-232.
8. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004;89:1045-50.
9. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C et al. A prospective study of the prevalence of primary aldosteronism in 1, 125 hypertensive patients. J Am Coll Cardiol 2006;48:2293-300.
10. Stowasser M, Gordon RD, Gunasekera TG, Cowley DC, Ward G, Archibald C et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. J Hypertens 2003;21:2149-57.
11. 2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism. Eur J Clin Invest 2009;39:43-50.
12. Balas M, Zosin I, Maser-Gluth C, Hermsen D, Cupisti K, Schott M et al. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism. Hypertens Res 2010;33:850-6.
13. Matrozova J, Steichen O, Amar L, Zacharieva S, Jeunemaitre X, Plouin PF. Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study. Hypertension 2009;53:605-10.
14. Devries C, Degoulet P, Jeunemaitre X, Sauquet D, Morice V, Chatellier G et al. Integrating management and expertise in a computerised system for hypertensive patients. Nephrol Dial Transplant 1987;2:327-31.
15. Heron E, Chatellier G, Billaud E, Foos E, Plouin PF. The urinary metanephrine-to-creatinine ratio for the diagnosis of pheochromocytoma. Ann Intern Med 1996;125:300-3.
16. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-43.
17. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem 2003;49:7-18.
18. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
19. Plouin PF. About an epidemic of primary aldosteronism. Hypertension 2008;51:e6. author reply e7.